NCT04235686 - 8 Week Multi-site Study of MYDAYIS® for Bipolar Depression | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 17, 2020

Primary Completion Date

July 25, 2025

Study Completion Date

July 25, 2025

Conditions

Bipolar Depression

Interventions

DRUG

Mydayis Extended-Release Capsule

Randomized, parallel - group, double-blind, placebo-controlled, flexible-dose adjunctive trial of MYDAYIS®

DRUG

Placebo

Matching placebo

Trial Locations (2)

Lindner Center of Hope, Mason

Mayo Clinic in Rochester, Rochester